Nexgel, Inc.
NXGL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $293.0K in total; no superinvestor holds it.
Other share classesNXGLW
Q1 2022 vs. Q4 2021
How the institutions holding Nexgel, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 111.0K | 50.5K | −60.4K (−54.5%) |
| Value | $289.0K | $98.0K | −$191.0K (−66.1%) |
New holders (4)
Institutions that held Nexgel, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 15,900 | $31.0K | 0.00% |
| Tekla Capital Management LLC | 4,243 | $8.00K | 0.00% |
| Wells Fargo & Company | 16 | $0 | 0.00% |
| Retirement Group, LLC | 3 | $0 | 0.00% |
Sold out (2)
Institutions that held Nexgel, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Altium Capital Management LP | 28,570 | $75.0K |
| Royal Bank of Canada | 38 | $0 |